Area of research
Immunology · Dermatology
Research interest
Research focused on Atopic dermatitis and Eczema Area and Severity Index, with related work in Acne, MAPK/ERK pathway, Placebo. Notable publications include 'VEGF induces proliferation of human hair follicle dermal papilla cells through VEGFR-2-mediated activation of ERK', 'Clinical practice Guidelines for 5-Aminolevulinic acid photodynamic therapy for acne vulgaris in China', and 'Efficacy and safety of CM310 in moderate-to-severe atopic dermatitis: A multicenter, randomized, double-blind, placebo-controlled phase 2b trial'.
Safety and efficacy of the selective tyrosine kinase 2/Janus kinase 1 inhibitor TLL-018 in moderate-to-severe plaque psoriasis: a phase Ib, randomized, double-blind, placebo-controlled study
Efficacy and Safety of Extending Dosing Interval of Stapokibart in Patients with Atopic Dermatitis
Efficacy and Safety of GR1802 in Patients With Moderate‐to‐Severe Atopic Dermatitis: A Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Phase 2 Trial
Long‐term efficacy and safety of stapokibart for moderate‐to‐severe atopic dermatitis: 52‐week results from a phase 3 trial
Long-Term Efficacy and Safety of Stapokibart in Adults with Moderate-to-Severe Atopic Dermatitis: An Open-Label Extension, Nonrandomized Clinical Trial
Expert Consensus on Big Data Collection of Skin and Appendage Disease Phenotypes in Chinese
Efficacy and safety of topical minocycline foam (FMX101 4%) in treatment of Chinese subjects with moderate‐to‐severe facial acne vulgaris: A phase 3, multi‐centre, randomized, double‐blind, vehicle‐controlled study
52574 Safety and efficacy of selective TYK2/JAK1 inhibitor, TLL-018, in moderate-to-severe plaque psoriasis
Efficacy and safety of CM310 in moderate-to-severe atopic dermatitis: A multicenter, randomized, double-blind, placebo-controlled phase 2b trial
Expert Consensus on the Treat-to-Target Strategy for Psoriasis With Biological Agents in China (Simplified Edition) #
Clinical practice Guidelines for 5-Aminolevulinic acid photodynamic therapy for acne vulgaris in China
Mupirocin blocks imiquimod-induced psoriasis-like skin lesion by inhibiting epidermal isoleucyl-tRNA synthetase
VEGF induces proliferation of human hair follicle dermal papilla cells through VEGFR-2-mediated activation of ERK
VEGF upregulates VEGF receptor-2 on human outer root sheath cells and stimulates proliferation through ERK pathway